Patents Assigned to The WWK Trust
  • Compositions for the enhanced treatment of depression
    Publication number: 20070173478
    Abstract: For treatment of endogenous depression, there is taken in combination an antidepressant, particularly an SSRI or SNRA, and a precursor or inducer of a neurotransmitter, e.g. L-phenylalanine, tyramine or L-tryptophan. Optionally, the patient also takes vitamin B12.
    Type: Application
    Filed: June 11, 2004
    Publication date: July 26, 2007
    Applicant: WWK TRUST
    Inventor: Andrew Worsley
  • Treatment of pain
    Patent number: 6451788
    Abstract: A method of treating pain by the co-administration of an antidepressant together with one or more precursors or inducers of neurotransmitters, particularly amino acids selected from L-phenylalanine, L-tyrosine, L-tryptophan and L-DOPA.
    Type: Grant
    Filed: January 4, 2000
    Date of Patent: September 17, 2002
    Assignee: The WWK Trust of 225-235 High Street
    Inventors: David Frederick Horrobin, Cari Loder, Graham Cooper
  • Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin B12 and/or precursors or inducers of a neurotransmitter
    Patent number: 6335323
    Abstract: Methods and compositions for treatment of a patient suffering from a form of peripheral neuropathy are disclosed. The method comprises administering to the patient any one of the following combinations of components: I. A, B and C; II. A and B; III. B and C; IV. A and C, wherein A is an antidepressant or a monoamine oxidase inhibitor, B is vitamin B12, and C is a precursor or inducer of a neurotransmitter, e.g. L-phenylalanine.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: January 1, 2002
    Assignee: The WWK Trust
    Inventor: Andrew Peter Worsley